Cerebral Therapeutics approach to regional brain drug delivery combines proprietary medications and a targeted micro-dosing implantable delivery method addresses the well-recognized limitations of oral medications including poor effectiveness, side effects, dosing limitations, variation in drug levels, limitations of the blood brain barrier and patient compliance.